Cargando…
Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer
Autores principales: | Wang, Bin, Fu, Jiantao, Lu, Anqian, Yang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151458/ https://www.ncbi.nlm.nih.gov/pubmed/35659914 http://dx.doi.org/10.1016/j.jinf.2022.05.030 |
Ejemplares similares
-
Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
por: Yan, Chi, et al.
Publicado: (2021) -
An integrative pan‐cancer analysis of the molecular and biological features of glycosyltransferases
por: Li, Yin, et al.
Publicado: (2022) -
Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations
por: Choi, Hongyoon, et al.
Publicado: (2018) -
ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2022) -
Pan endocrine curriculum
por: Lodha, Sailesh, et al.
Publicado: (2015)